Systemic Sclerosis Imaging
Updated: Jan 14, 2022
Author: Tracy Elliot, MD, HBSc, FRCPC; Chief Editor: Eugene C Lin, MD
Practice Essentials
Systemic sclerosis is a multisystem disease of connective tissue that is accompanied by vasculopathy. Scleroderma, its original name, means hard skin. Progressive systemic sclerosis (PSS) is a connective tissue disease associated with small vessel arterial vasculopathy and inflammatory and immunologic processes. The peak incidence is between 45 and 64 years of age.[1, 2] Clinically, PSS is classified as diffuse or limited depending on the distribution of skin disease. PSS is considered limited when involvement is restricted to the distal extremities and face. The limited form is associated with a lower risk of visceral involvement, although pulmonary hypertension is more common.[3, 4, 5, 6]
Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis. High-resolution CT is recommended in all patients with the disease.[7, 8, 9, 10, 11] Risk stratification by measuring the extent of disease on HRCT of the chest, by longitudinal decline in pulmonary function tests (PFTs), and by mortality prediction models help identify significant interstitial lung disease.[12, 13]
(See the images below.)
Posteroanterior chest radiograph reveals irregular reticular opacities in the lower lobes. Two years later, the findings are more marked.
High-resolution CT of biopsy-proven nonspecific interstitial pneumonia. The image shows abnormal reticular opacities in a background of ground-glass opacity, with associated traction bronchiectasis indicating lung fibrosis.
Diffuse cutaneous systemic sclerosis (dcSSc) and limited cutaneous systemic sclerosis (lcSSc) scleroderma overlap the following syndromes[14] :
-
CREST syndrome (calcinosis, Raynaud phenomenon, esophageal dysmotility, skin pigmentation, telangiectasias)
-
Mixed connective tissue disease (controversial whether this is a separate entity or an intermediate stage in the progression to connective tissue disease)
-
Scleromyositis (coexisting features of dermatomyositis without features of systemic lupus erythematosus)
-
Polymyositis synthetase (interstitial lung disease, myositis, Raynaud phenomenon, arthritis)
-
Morphea (focal cutaneous scleroderma)
Imaging modalities
Chest radiography is insensitive, since findings are abnormal in only two thirds of patients with pulmonary disease.
High-resolution computed tomography (HRCT) scanning is the best imaging test for assessing the extent and severity of pulmonary disease. Reported detection of fibrosis with HRCT is 60-90%, compared with 60-100% at autopsy.[15, 16, 17, 18, 19, 1, 20, 21] HRCT findings are abnormal in most patients with functional impairment. False-negative HRCT imaging study findings have occurred in the setting of alveolitis using bronchoalveolar lavage in patients with normal pulmonary function tests.[22]
Echocardiographic measurements of systolic pulmonary arterial pressure correlate well with right heart catheterization values.[23] Early detection of cardiac and renal involvement even in asymptomatic patients is recommended to avoid further complications. Cardiac magnetic resonance imaging has been found to identify markers for vacular and fibrotic damage.[24]
Echocardiography is the most frequently used modality for pulmonary artery hypertension, which is present in 10-15% of patients with systemic sclerosis. The specificity and sensitiviy of echocardiography are 75% and 90%, respectively.[8]
High-resolution ultrasound imaging of skin involvement may be helpful to quantitatively evaluate dermal thickness in systemic sclerosis.[9, 25, 26] In some studies, lung ultrasonography has been identified as a noninvasive, radiation-free technique for the diagnosis of interstitial lung disease with both high sensitivity and high specificity.[27, 28, 29]
Radiographs in women who are pregnant are limited to a single PA view to minimize radiation exposure. Shielding is used when appropriate. If HRCT examination is considered essential during pregnancy, it can be tailored to minimize radiation exposure.
Intervention
A collaborative approach between pulmonologists and thoracic radiologists is important in the diagnosis and management of interstitial lung disease. Analysis of HRCT images of the chest can guide video-assisted thoracoscopic lung biopsy. An increased incidence of lung cancer is seen in patients with scleroderma, and the radiologist is involved in detection and diagnosis through CT-guided percutaneous lung biopsy.
Perform percutaneous drainage of complicated parapneumonic effusions and empyemas with CT or ultrasonographic guidance.
Radiography
Early radiographic findings include subpleural reticular or reticulonodular opacity in a basal predominant distribution.
Late radiographic findings include the following:
-
Fibrotic changes involving the lower two thirds of the lung, with associated volume loss and honeycombing
-
Pulmonary artery enlargement and cardiomegaly
Ancillary findings include diffuse esophageal dilation with a resultant "air esophagram sign," which is useful when present to differentiate progressive systemic sclerosis (PSS) from idiopathic pulmonary fibrosis (IPF), asbestosis, and rheumatoid arthritis.
(See the image below.)
Posteroanterior chest radiograph reveals irregular reticular opacities in the lower lobes. Two years later, the findings are more marked.
Chest radiography is relatively insensitive in early disease, and findings may be minimal even in advanced disease; however, chest radiographic findings are observed in as many as two thirds of symptomatic patients, with findings suggestive of fibrosis demonstrated in 25-45% of patients.
(See the image below.)
Posteroanterior and lateral chest radiographs reveal hazy opacity in both bases, with elevation of diaphragms suggestive of restrictive lung disease.
Interstitial lung disease with a predominant lower lobe distribution on chest radiography may have numerous etiologies, including PSS. Clinical history and esophageal dilation on radiographs suggest PSS. Any phase of IPF, asbestosis, interstitial pulmonary edema, lymphangitic metastases, pulmonary hemorrhage, and other diffuse lung diseases may mimic PSS on chest radiographs. On the posteroanterior (PA) view, the breast shadows can mimic increased markings over the lower lung zones. Lateral view is critical so as to obtain a less obscured view of the lower lobes.
Computed Tomography
Patients with suggested or known diagnosis of PSS should undergo the following examinations[30] :
-
Standard resolution CT (SRCT) to exclude a lung neoplasm (which is slightly more common than in the general population) and to evaluate pleuropericardial, esophageal, cardiac, and pulmonary arterial abnormalities
-
HRCT to evaluate lung parenchymal involvement
Interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis. High-resolution CT is recommended in all patients with the disease.[7, 8, 9, 10, 11]
Imaging findings
Pulmonary fibrosis and pulmonary hypertension are the most common findings. Overlap syndromes or CREST syndrome are suggested when pulmonary hypertension is out of proportion to the degree of fibrosis.
HRCT findings of pulmonary fibrosis include the following:
-
-
Subpleural cysts or honeycombing
-
Irregular reticular opacities (seen in the image below)
High-resolution CT of biopsy-proven nonspecific interstitial pneumonia. The image shows abnormal reticular opacities in a background of ground-glass opacity, with associated traction bronchiectasis indicating lung fibrosis.
-
Interlobular septal thickening
-
Traction bronchiectasis (seen in the image below) and bronchiolectasis
High-resolution CT reveals intralobular interstitial thickening and mild traction bronchiectasis in the lung base, with progression over a 2-year period.
-
Visceral pleural thickening
-
Ground-glass opacity may indicate acute inflammation (alveolitis). Honeycombing (demonstrated in the image below) favors a histologic usual interstitial pneumonitis (UIP) pattern.
High-resolution CT demonstrates extensive basal honeycombing suggestive of lung fibrosis. Note the extraluminal peritoneal cavity air presumed to be secondary to benign pneumatosis intestinalis and the dilated esophagus with an air-fluid level.
Mixed reticulation and ground-glass opacity with little or absent honeycombing favor histologic nonspecific interstitial pneumonia (NSIP).
Distribution of disease
Fibrosis is subpleural and basal predominant.
A less marked involvement of the upper lobes favors PSS or other collagen vascular disease as the etiologic cause of the UIP pattern, rather than IPF or chronic hypersensitivity pneumonitis.
HRCT identified fibrotic interstitial lung disease (ILD) in 16 of 43 patients with systemic sclerosis. The main pattern of ILD was identified with nonspecific interstitial pneumonia (NSIP).[20]
Ancillary findings
Mediastinal adenopathy is found; the prevalence is increased in more extensive lung disease. Esophageal dilation is present on CT scans in 80% of patients with diffuse lung disease resulting from PSS.
Degree of confidence
Studies have shown that HRCT is diagnostically accurate in specific subsets of patients with diffuse lung disease. In a study of 85 patients with diffuse lung disease by Swensen et al,[31] radiologists more frequently had a high level of confidence in diagnosing UIP than any other pattern and listed it as the number one diagnosis in 89% of patients with that histologic finding. Imaging diagnoses were most accurate (90% correct) when a high level of confidence was present.
Remy-Jardin and colleagues correlated HRCT findings with functional parameters and bronchoalveolar lavage (BAL) results in patients with PSS.[22] BAL findings were abnormal in 7 of 21 patients with normal imaging and PFTs, suggesting that it is more sensitive than HRCT in detecting subclinical alveolitis. The extent of parenchymal destruction, which correlated with functional abnormality, was better depicted by HRCT.
Diot and colleagues assigned point values to each abnormal finding present on HRCT of 52 patients with progressive systemic sclerosis (PSS). Total scores were inversely proportional to total lung capacity and diffusing capacity for carbon monoxide (DLCO). Receiver operator curve analysis demonstrated that an HRCT score of 7 or greater minimized false negatives (sensitivity of 0.60) while achieving a specificity of 0.83. The positive predictive value of HRCT in this study was 0.82.[15]
False negatives have been documented in patients with subclinical alveolitis.[22]
Author
Tracy Elliot, MD, HBSc, FRCPC Assistant Professor, Department of Radiology, University of Alberta Faculty of Medicine and Dentistry, Canada
Tracy Elliot, MD, HBSc, FRCPC is a member of the following medical societies: Alberta Medical Association, Canadian Association of Radiologists, Radiological Society of North America, Royal College of Physicians and Surgeons of Canada, Society of Thoracic Radiology
Disclosure: Nothing to disclose.
Specialty Editor Board
Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Chief Editor
Eugene C Lin, MD Attending Radiologist, Teaching Coordinator for Cardiac Imaging, Radiology Residency Program, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, Society of Nuclear Medicine and Molecular Imaging
Disclosure: Nothing to disclose.
Additional Contributors
Judith K Amorosa, MD, FACR Clinical Professor of Radiology and Vice Chair for Faculty Development and Medical Education, Rutgers Robert Wood Johnson Medical School
Judith K Amorosa, MD, FACR is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, Society of Thoracic Radiology
Disclosure: Nothing to disclose.
Al-Jahdali H, Rajiah P, Allen C, Koteyar SS, Khan AN. Pictorial review of intrathoracic manifestations of progressive systemic sclerosis. Ann Thorac Med. 2014 Oct. 9 (4):193-202. [QxMD MEDLINE Link].
Yaqub A, Chung L. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep. 2013 Jan. 15 (1):302. [QxMD MEDLINE Link].
van Laar JM, Stolk J, Tyndall A. Scleroderma lung: pathogenesis, evaluation and current therapy. Drugs. 2007. 67(7):985-96. [QxMD MEDLINE Link].
Antoniou KM, Wells AU. Scleroderma lung disease: evolving understanding in light of newer studies. Curr Opin Rheumatol. 2008 Nov. 20(6):686-91. [QxMD MEDLINE Link].
Liu T, McCalmont TH, Frieden IJ, Williams ML, Connolly MK, Gilliam AE. The stiff skin syndrome: case series, differential diagnosis of the stiff skin phenotype, and review of the literature. Arch Dermatol. 2008 Oct. 144(10):1351-9. [QxMD MEDLINE Link].
Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med. 2007 Aug. 28(4):369-78. [QxMD MEDLINE Link].
Hoa S, Baron M, Hudson M. Screening and management of subclinical interstitial lung disease in systemic sclerosis: an international survey. Rheumatology (Oxford). 2021 Dec 16. [QxMD MEDLINE Link].
Rutka K, Garkowski A, Karaszewska K, Łebkowska U. Imaging in Diagnosis of Systemic Sclerosis. J Clin Med. 2021 Jan 12. 10 (2):[QxMD MEDLINE Link].
Hesselstrand R, Carlestam J, Wildt M, Sandqvist G, Andréasson K. High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study. Arthritis Res Ther. 2015 Nov 19. 17:329. [QxMD MEDLINE Link].
Chung JH, Walker CM, Hobbs S. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease. J Vis Exp. 2020 Jun 16. [QxMD MEDLINE Link].
Forestier A, Le Gouellec N, Béhal H, et al. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors. Semin Arthritis Rheum. 2020 Dec. 50 (6):1406-1413. [QxMD MEDLINE Link].
DeMizio DJ, Bernstein EJ. Detection and classification of systemic sclerosis-related interstitial lung disease: a review. Curr Opin Rheumatol. 2019 Nov. 31 (6):553-560. [QxMD MEDLINE Link].
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013 Nov. 65 (11):2737-47. [QxMD MEDLINE Link].
Phillips K, Byrne-Dugan C, Batterson E, Seibold JR. Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis. Nat Rev Rheumatol. 2009 Apr. 5 (4):225-8. [QxMD MEDLINE Link].
Diot E, Boissinot E, Asquier E, et al. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis. Chest. 1998 Dec. 114(6):1623-9. [QxMD MEDLINE Link].
Devenyi K, Czirjak L. High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma. Clin Rheumatol. 1995 Nov. 14(6):633-40. [QxMD MEDLINE Link].
Pignone A, Matucci-Cerinic M, Lombardi A, et al. High resolution computed tomography in systemic sclerosis. Real diagnostic utilities in the assessment of pulmonary involvement and comparison with other modalities of lung investigation. Clin Rheumatol. 1992 Dec. 11(4):465-72. [QxMD MEDLINE Link].
Wells AU, Hansell DM, Corrin B, et al. High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax. 1992 Sep. 47(9):738-42. [QxMD MEDLINE Link].
Steele R, Hudson M, Lo E, Baron M. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis. Arthritis Care Res (Hoboken). 2012 Apr. 64(4):519-24. [QxMD MEDLINE Link].
Zompatori M, Leone MB, Giannotta M, Galiè N, Palazzini M, Reggiani ML, et al. Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography. Radiol Med. 2013 Dec. 118 (8):1360-72. [QxMD MEDLINE Link].
Rabinovich CE. Challenges in the diagnosis and treatment of juvenile systemic sclerosis. Nat Rev Rheumatol. 2011 Oct 11. 7 (11):676-80. [QxMD MEDLINE Link].
Remy-Jardin M, Remy J, Wallaert B, et al. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology. 1993 Aug. 188(2):499-506. [QxMD MEDLINE Link].
Denton CP, Cailes JB, Phillips GD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol. 1997 Feb. 36(2):239-43. [QxMD MEDLINE Link].
Cianci R, Gigante A, Gasperini ML, Barbano B, Galea N, Rosato E. Late Gadolinium Enhancement in Cardiac Magnetic Resonance Imaging Is Associated with High Renal Resistive Index in Patients with Systemic Sclerosis. Kidney Blood Press Res. 2020. 45 (2):350-356. [QxMD MEDLINE Link].
Dźwigała M, Sobolewski P, Maślińska M, Yurtsever I, Szymańska E, Walecka I. High-resolution ultrasound imaging of skin involvement in systemic sclerosis: a systematic review. Rheumatol Int. 2021 Feb. 41 (2):285-295. [QxMD MEDLINE Link].
Ruaro B, Santiago T, Hughes M, Lepri G, Poillucci G, Baratella E, et al. The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis. Open Access Rheumatol. 2021. 13:79-91. [QxMD MEDLINE Link]. [Full Text].
Ferro F, Delle Sedie A. The use of ultrasound for assessing interstitial lung involvement in connective tissue diseases. Clin Exp Rheumatol. 2018 Sep-Oct. 36 Suppl 114 (5):165-170. [QxMD MEDLINE Link].
Xie HQ, Zhang WW, Sun S, et al. A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis. Arthritis Res Ther. 2019 Apr 11. 21 (1):93. [QxMD MEDLINE Link].
Hassan RI, Lubertino LI, Barth MA, et al. Lung Ultrasound as a Screening Method for Interstitial Lung Disease in Patients With Systemic Sclerosis. J Clin Rheumatol. 2019 Oct. 25 (7):304-307. [QxMD MEDLINE Link].
Kim HJ, Li G, Gjertson D, Elashoff R, Shah SK, Ochs R, et al. Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study. Acad Radiol. 2008 Aug. 15(8):1004-16. [QxMD MEDLINE Link].
Swensen SJ, Aughenbaugh GL, Myers JL. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology. 1997 Oct. 205(1):229-34. [QxMD MEDLINE Link].